UK markets closed

Renalytix Plc (RNLX)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
0.6288+0.0047 (+0.75%)
At close: 04:00PM EDT
0.6388 +0.01 (+1.59%)
After hours: 07:01PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 39.09M
Enterprise value 40.74M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)12.09
Price/book (mrq)15.04
Enterprise value/revenue 16.90
Enterprise value/EBITDA -1.10

Trading information

Stock price history

Beta (5Y monthly) 1.91
52-week change 3-71.01%
S&P500 52-week change 322.36%
52-week high 34.0380
52-week low 30.2450
50-day moving average 30.8828
200-day moving average 31.2956

Share statistics

Avg vol (3-month) 31.89M
Avg vol (10-day) 3211.3k
Shares outstanding 563.78M
Implied shares outstanding 647.55M
Float 858.02M
% held by insiders 13.62%
% held by institutions 16.57%
Shares short (15 Apr 2024) 4673.72k
Short ratio (15 Apr 2024) 40.41
Short % of float (15 Apr 2024) 4N/A
Short % of shares outstanding (15 Apr 2024) 41.09%
Shares short (prior month 15 Mar 2024) 4894.62k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,175.60%

Management effectiveness

Return on assets (ttm)-88.32%
Return on equity (ttm)-651.40%

Income statement

Revenue (ttm)2.41M
Revenue per share (ttm)0.05
Quarterly revenue growth (yoy)-40.50%
Gross profit (ttm)N/A
EBITDA -37.79M
Net income avi to common (ttm)-41.85M
Diluted EPS (ttm)-0.9000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)5.62M
Total cash per share (mrq)0.06
Total debt (mrq)8.48M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.59
Book value per share (mrq)-0.08

Cash flow statement

Operating cash flow (ttm)-36.16M
Levered free cash flow (ttm)-19.77M